Drug Lobby Spends Record Amount in Fight Over Medicine Costs (1)

Jan. 22, 2020, 3:59 PM

The main lobbying association for drug makers, the Pharmaceutical Research and Manufacturers of America, spent a record $28.9 million on lobbying last year as it pushed back on legislation meant to control the price of medicine.

The trade group asked lawmakers instead to create an out-of-pocket cap for prescription drugs under Medicare instead of going after drug prices.

The amount spent by PhRMA was up 5% from the year before, according to the federal lobbying disclosures filed Tuesday.

PhRMA representatives landed a crucial meeting with President Donald Trump last summer to discuss pricing. The industry is concerned about a proposal ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.